Literature DB >> 21689902

Cognitive behavior therapy in medication non-responders with obsessive-compulsive disorder: a prospective 1-year follow-up study.

Nitin Anand1, Paulomi M Sudhir, Suresh Bada Math, K Thennarasu, Y C Janardhan Reddy.   

Abstract

Evidence of efficacy of cognitive behavior therapy (CBT) in obsessive-compulsive disorder (OCD) non-responsive to multiple trials of serotonin reuptake inhibitors (SRI) is limited. We examined the efficacy of CBT in 31 adult patients with DSM-IV OCD who were non-responders to at least two SRI trials. They received 20-25 sessions of CBT over 3-month duration. The primary outcome measure was "response" to treatment [Clinical Global Impressions-Improvement score 1 or 2 and ≥35% reduction in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) severity score]. Patients were assessed at baseline, post-treatment and at 3-, 6- and 12-month follow-up. Twenty-six (84%) patients completed treatment and number of responders at post-treatment, 3-, 6- and 12-month follow-up were 23 (74%), 20 (64%), 20 (64%) and 19 (61%) respectively. Quality of homework compliance and baseline Y-BOCS severity predicted remission (Y-BOCS<16) to CBT. CBT is useful in OCD non-responsive to multiple trials of SRI.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21689902     DOI: 10.1016/j.janxdis.2011.05.007

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  9 in total

1.  Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods.

Authors:  Christina L Boisseau; Steven A Rasmussen
Journal:  Contemp Clin Trials       Date:  2018-01-03       Impact factor: 2.226

2.  Long-term Outcomes of Intensive Inpatient Care for Severe, Resistant Obsessive-Compulsive Disorder: Résultats à long terme de soins intensifs à des patients hospitalisés pour un trouble obsessionnel-compulsif grave et résistant.

Authors:  Srinivas Balachander; Aakash Bajaj; Nandita Hazari; Ajay Kumar; Nitin Anand; M Manjula; Paulomi M Sudhir; Anish V Cherian; Janardhanan C Narayanaswamy; T S Jaisoorya; Suresh Bada Math; Thennarasu Kandavel; Shyam Sundar Arumugham; Y C Janardhan Reddy
Journal:  Can J Psychiatry       Date:  2020-05-26       Impact factor: 4.356

3.  Exposure and response prevention helps adults with obsessive-compulsive disorder who do not respond to pharmacological augmentation strategies.

Authors:  Carmen P McLean; Laurie J Zandberg; Page E Van Meter; Joseph K Carpenter; Helen Blair Simpson; Edna B Foa
Journal:  J Clin Psychiatry       Date:  2015-12       Impact factor: 4.384

4.  An Atypical and Resistant Case of Obsessive Compulsive Disorder Responding Satisfactorily with an Unusual way of Exposure and Response Prevention Therapy.

Authors:  Kamal Nath; Robin Victor; Subrata Naskar
Journal:  J Clin Diagn Res       Date:  2016-03-01

Review 5.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

6.  Who gets the most out of cognitive behavioral therapy for anxiety disorders? The role of treatment dose and patient engagement.

Authors:  Daniel Glenn; Daniela Golinelli; Raphael D Rose; Peter Roy-Byrne; Murray B Stein; Greer Sullivan; Alexander Bystritksy; Cathy Sherbourne; Michelle G Craske
Journal:  J Consult Clin Psychol       Date:  2013-06-10

7.  Homework adherence predicts therapeutic improvement from behavior therapy in Tourette's disorder.

Authors:  Joey K-Y Essoe; Emily J Ricketts; Kesley A Ramsey; John Piacentini; Douglas W Woods; Alan L Peterson; Lawrence Scahill; Sabine Wilhelm; John T Walkup; Joseph F McGuire
Journal:  Behav Res Ther       Date:  2021-03-13

8.  Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial.

Authors:  Hamid Afshar; Shahla Akuchekian; Behzad Mahaky; Elham Zarean
Journal:  J Res Med Sci       Date:  2014-10       Impact factor: 1.852

9.  Efficacy of mindfulness-integrated cognitive behavior therapy in patients with predominant obsessions.

Authors:  Ajay Kumar; Mahendra P Sharma; Janardhanan C Narayanaswamy; Thennarasu Kandavel; Y C Janardhan Reddy
Journal:  Indian J Psychiatry       Date:  2016 Oct-Dec       Impact factor: 1.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.